From the Journals
September 26, 2024
Breast Cancer Diagnosis: 55% Gain in Efficiency With AI-Assisted Pathology
Conexiant
September 26, 2024
Neighborhood Environment May Be Linked to Prostate Cancer Risk in Men With West African Genetic Ancestry
The ASCO Post
September 26, 2024
HARMONi-2: Ivonescimab Outperforms Pembrolizumab as First-Line Treatment in NSCLC
The ASCO Post
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
September 24, 2024
The Formative Years of Medical Oncology in the United States: A Rough and Tumble Road, Part 1
The ASCO Post
September 24, 2024
Black Patients With Triple-Negative Breast Cancer May Be Less Likely to Receive Immunotherapy Compared With White Patients
The ASCO Post
September 24, 2024
Combination Targeted Therapy Produces Durable Remissions in Some Patients With Relapsed Diffuse Large B-Cell Lymphoma
The ASCO Post
September 24, 2024
Ifinatamab Deruxtecan Shows Activity in Extensive-Stage Small Cell Lung Cancer
The ASCO Post
Advertisement
Recommendations
Advertisement